Correction to: Scientific Reports https://doi.org/10.1038/s41598-020-66611-8, published online 12 June 2020
The Acknowledgements section in this Article was omitted. The Acknowledgements section should read:
“The work has been funded by the Operational Programme Human Capital of the Ministry of European Funds through the Financial Agreement 51675/09.07.2019, SMIS code 125125.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Valeanu, A., Damian, C., Marineci, C.D. et al. Author Correction: The development of a scoring and ranking strategy for a patient-tailored adverse drug reaction prediction in polypharmacy. Sci Rep 11, 5918 (2021). https://doi.org/10.1038/s41598-021-85551-5
Published:
DOI: https://doi.org/10.1038/s41598-021-85551-5
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
